Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Sirolimus × 90 days × Clear all

Sponsor

Conditions

Hematologic Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Rhabdomyosarcoma 3 Neoplasms 3 Sarcoma, Ewing 2 Sarcoma 2 Rhabdoid Tumor 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroblastoma 2 Neoplasms, Germ Cell and Embryonal 2 Myelodysplastic Syndromes 2 Melanoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Bronchiolitis Obliterans Syndrome 2 Brain Neoplasms 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Tufted angioma 1 Tuberous Sclerosis 1 Thrombocytopenia 1 Skin Neoplasms 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Refractory Solid Tumors in Children 1 Recurrence 1 Pseudomyxoma Peritonei 1 Pinealoma 1 PRETEXT I Hepatoblastoma 1

Interventions

pembrolizumab 18 Radiotherapy 10 Cisplatin 10 Carboplatin 9 Cetuximab 8 Paclitaxel 7 Drug Therapy 4 Radiotherapy, Intensity-Modulated 3 Nivolumab 3 Docetaxel 3 toripalimab 2 tislelizumab 2 palbociclib 2 osimertinib 2 fludarabine 2 X-Rays 2 Surveys and Questionnaires 2 Standard of Care 2 Radiation 2 Pravastatin 2 Magnetic Resonance Spectroscopy 2 Ketoprofen 2 Fulvestrant 2 Fluorouracil 2 Equipment and Supplies 2 Cyclophosphamide 2 Chemoradiotherapy 2 Blood Specimen Collection 2 Afatinib 2 ulixertinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡